Benefactors of the Tim Nesvig Lymphoma Fellowship and Research Fund like you are contributing to science that may eradicate lymphoma and the suffering it causes. Through your generous donations, the fund has grown to more than $10 million — financial support that advances City of Hope’s in-depth research into how this disease develops and how we can cure it.
Every day, my staff and I see patients who are bravely battling lymphoma, as Tim did. Often, they are surrounded by loving family members and friends, as Tim was. The Nesvig Fund brings new hope to these patients and their loved ones. Better choices and better chances to beat this terrible disease may be on the horizon, thanks to the research of our Tim Nesvig Fellows and other researchers supported by the fund.
The recipients of the Tim Nesvig Lymphoma Fellowship and Research Fund explore innovative methods to defeat lymphoma. They seek ways to make lifesaving bone marrow transplants safer. They search out lymphoma’s weaknesses so they can develop new, more-effective therapies that have less-toxic side effects. Their investigations hold the potential to save countless lives worldwide, and the boost provided by the Nesvig Fund makes a significant difference in moving their research forward. For more information about the progress we have made with the help of these funds, please click the "Tim Nesvig Lymphoma Fellowship" and “Current Nesvig Projects” links at left.
At City of Hope, our research is guided by the same commitment to compassion that defines how we treat our patients and their families, best expressed by the credo, “There is no profit in curing the body if, in the process, we destroy the soul.” Time is precious for those who face lymphoma. That is why we want to accelerate the process of developing better therapies and bringing them to patients.
By contributing to the Tim Nesvig Lymphoma Fellowship and Research Fund, you affirm your commitment to scientific excellence and demonstrate your advocacy for the tens of thousands who face lymphoma each year. On behalf of all of my colleagues in the Department of Hematology & Hematopoietic Cell Transplantation and the patients of today and tomorrow, I offer you my deepest gratitude for your support.
Sincerely,
Francis and Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation
Chair, Division of Hematology & Hematopoietic Cell Transplantation
